Waldron Private Wealth’s Cantel Medical Corporation CMD Stock Holding History

Waldron Private Wealth’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-3,630	Closed	-$292K	–	278
2019 Q2	$292K	Hold	3,630	–	–	0.03%	188
2019 Q1	$242K	Buy	3,630 +700	+24%	+$53K	0.03%	219
2018 Q4	$218K	Hold	2,930	–	–	0.03%	193
2018 Q3	$269K	Buy	2,930 +360	+14%	+$34.3K	0.05%	155
2018 Q2	$252K	Sell	2,570 -3	-0.1%	-$336	0.05%	148
2018 Q1	$286K	Hold	2,573	–	–	0.06%	134
2017 Q4	$264K	Buy	2,573 +105	+4%	+$10.5K	0.06%	138
2017 Q3	$232K	Buy	+2,468	New	+$195K	0.06%	130
2017 Q2	–	Sell	-3,386	Closed	-$271K	–	218
2017 Q1	$271K	Buy	+3,386	New	+$269K	0.07%	175

Other funds holding CMD

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Waldron Private Wealth's CMD Position: Q3 2019 in Review

Waldron Private Wealth sold out of Cantel Medical Corporation (CMD) in Q3 2019, closing a stake of 3,630 shares — an estimated $292K sold.

Waldron Private Wealth first reported a position in CMD in Q1 2017 and held it in 9 quarters. The position peaked at $292K in Q2 2019. 244 funds tracked by Wall St. Rank hold CMD as of Q3 2019.

Waldron Private Wealth reported no remaining Cantel Medical Corporation position as of Q3 2019 after selling out during the quarter.
Waldron Private Wealth sold 3,630 Cantel Medical Corporation shares in Q3 2019, an estimated $292K.
Waldron Private Wealth first reported a position in Cantel Medical Corporation in Q1 2017 and held it in 9 quarters.
Waldron Private Wealth's Cantel Medical Corporation position peaked at $292K in Q2 2019.
244 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2019.

Based on Waldron Private Wealth's 13F filing for Q3 2019, filed 6 Nov 2019.